ArticlePharmaceutical research2025

A Proposal for Alternative FDA Bioequivalence Criteria for Narrow Therapeutic Index Drug Products to Support Future Harmonization.

Wanjie Sun et al.PubMed ↗Publisher ↗

No numbers read from the abstract.